Journal of the Korean Ophthalmological Society 2005;46(7):1151-1157.
Published online July 31, 2005.
Neovascular Glaucoma: Diode Laser Trans-Scleral Cyclophotocoaculation Versus Ahmed Glaucoma Valve Implant.
Seong Hee Min, Yun Seok Chung, Hwang Ki Kim, Yong Ho Sohn
Myung-Gok Eye Research Institute, Department of Ophthalmology, Konyang University, Kim's Eye Hospital, Seoul, Korea. yhsohn@konyang.ac.kr
신생혈관 녹내장에서 경공막 다이오드레이저 모양체광응고술과 아메드 녹내장밸브 삽입술의 비교
민성희,정윤석,김황기,손용호
Myung-Gok Eye Research Institute Department of Ophthalmology, Konyang University, Kim’s Eye Hospital, Seoul, Korea
Correspondence:  Seong-Hee Min, M.D.
Abstract
PURPOSE
To retrospectively study the clinical outcomes of diode laser trans-scleral cyclophotocoagulation and Ahmed glaucoma valve implant in eyes with neovascular glaucoma. METHODS: We reviewed the medical records of patients who had undergone diode laser trans-scleral cyclophotocoagulation (group 1) and Ahmed glaucoma valve implant (group 2) with a follow-up period of 6 months or longer. The treatments were carried out to control high intraocular pressure (IOP) and ocular pain in the patients with visual acuity less than hand motions. RESULTS: Group 2 had a significantly lower IOP during the first postoperative month. The cumulative probability of success was higher in group 2 than group 1 throughout the follow-up period. The postoperative complications in most cases were transient and improved with conservative management in both groups. However, 3 cases in group 1 required evisceration secondary to phthisis. Subjective relief of ocular pain was higher in group 2. CONCLUSIONS: The Ahmed glaucoma valve implant group showed a higher success rate and fewer serious complications than the diode laser trans-scleral cyclophotocoagulation group in patients with high IOP and ocular pain with poor visual acuity. Diode laser trans-scleral cyclophotocoagulation may be considered in patients with poor general health.
Key Words: Ahmed glaucoma valve implant;Cyclophotocoagulation;Neovascular glaucoma


ABOUT
BROWSE ARTICLES
EDITORIAL POLICY
FOR CONTRIBUTORS
Editorial Office
SKY 1004 Building #701
50-1 Jungnim-ro, Jung-gu, Seoul 04508, Korea
Tel: +82-2-583-6520    Fax: +82-2-583-6521    E-mail: kos08@ophthalmology.org                

Copyright © 2024 by Korean Ophthalmological Society.

Developed in M2PI

Close layer
prev next